Edwards Lifesciences

Medical Equipment

$ 97 1.5

Share price

$ 61 bn

Market Cap

$ 65 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.03x the weighted average for S&P 500

FY2020

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Edwards Lifesciences reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 46 Kt (+4.4/+11% y-o-y). Carbon intensity also was up at 11 t (+0.9/+9.4% y-o-y).

Edwards Lifesciences's Scope 3 emissions plummeted to 31 Kt (-20 /-39.4% y-o-y). The time series has been volatile over the last few periods.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Date	Total CO2e emissions (market-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2020Q4	46	14	32	31	4,386	11
2019Q4	42	14	28	52	4,348	9.6
2018Q4		13		47	3,723
2017Q4		11		45	3,435
2016Q4		6.1		41	2,964
2015Q4		5.4		37	2,494

Edwards Lifesciences

Carbon footprint

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Edwards Lifesciences's carbon footprint

Company environmental metrics